Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer

NCT01759238 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped unexpectedly slow recruitment

Conditions

Colorectal Cancer
Metastases

Interventions

DRUG: Capecitabine
DRUG: Bevacizumab
RADIATION: Radiotherapy

Sponsor

Universitätsklinikum Hamburg-Eppendorf